6:31 am Foundation Medicine announces results of a new study demonstrating that FoundationOne identified genomic alterations linked to targeted therapies or clinical trials in 71% (20/28) of patients with intrahepatic cholangiocarcinoma; da
View todays social media effects on FMI
View the latest stocks trending across Twitter. Click to view dashboard
See who Foundation is hiring next, click here to view
